** Shares of Israel-based medical technology company InMode INMD.O fall 2% to $14.60 premarket
** INMD expects Q1 revenue in range of $77.2 million and $77.5 million, compared with analysts' average estimate of $82.2 million, according to data compiled by LSEG
** Company reiterates 2025 revenue forecast between $395 million and $405 million
** As of last close, INMD down 10.9% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.